Cargando…

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

Detalles Bibliográficos
Autores principales: Zhang, Shannon S., Ou, Sai-Hong Ignatius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422432/
https://www.ncbi.nlm.nih.gov/pubmed/36046400
http://dx.doi.org/10.1016/j.jtocrr.2022.100358
_version_ 1784777810806571008
author Zhang, Shannon S.
Ou, Sai-Hong Ignatius
author_facet Zhang, Shannon S.
Ou, Sai-Hong Ignatius
author_sort Zhang, Shannon S.
collection PubMed
description
format Online
Article
Text
id pubmed-9422432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94224322022-08-30 Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors Zhang, Shannon S. Ou, Sai-Hong Ignatius JTO Clin Res Rep Editorial Elsevier 2022-08-17 /pmc/articles/PMC9422432/ /pubmed/36046400 http://dx.doi.org/10.1016/j.jtocrr.2022.100358 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Zhang, Shannon S.
Ou, Sai-Hong Ignatius
Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
title Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
title_full Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
title_fullStr Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
title_full_unstemmed Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
title_short Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
title_sort moving the needle cautiously in targeting one of the most often acquired receptor tyrosine fusion (ret fusion) resistance mechanisms to egfr tyrosine kinase inhibitors
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422432/
https://www.ncbi.nlm.nih.gov/pubmed/36046400
http://dx.doi.org/10.1016/j.jtocrr.2022.100358
work_keys_str_mv AT zhangshannons movingtheneedlecautiouslyintargetingoneofthemostoftenacquiredreceptortyrosinefusionretfusionresistancemechanismstoegfrtyrosinekinaseinhibitors
AT ousaihongignatius movingtheneedlecautiouslyintargetingoneofthemostoftenacquiredreceptortyrosinefusionretfusionresistancemechanismstoegfrtyrosinekinaseinhibitors